Elevated levels of STAT3 tyrosine phosphorylation have been detected in glioma specimens or cells, indicating activation of STAT3 [24–26], and glioma patients with a high proportion of STAT3 phosphorylation-positive cells were found to have shorter survival than those with a low proportion [27]. This evidence concerns the gene STAT3 and central nervous system cancer.